These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 22345097)
1. The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition. Li B; Ren H; Yue P; Chen M; Khuri FR; Sun SY Cancer Prev Res (Phila); 2012 Apr; 5(4):612-20. PubMed ID: 22345097 [TBL] [Abstract][Full Text] [Related]
2. Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis. Chen S; Fu L; Raja SM; Yue P; Khuri FR; Sun SY Mol Cancer; 2010 Jan; 9():23. PubMed ID: 20113484 [TBL] [Abstract][Full Text] [Related]
3. The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition. Yao W; Yue P; Khuri FR; Sun SY Oncotarget; 2015 Oct; 6(33):34669-79. PubMed ID: 26415225 [TBL] [Abstract][Full Text] [Related]
4. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression. Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887 [TBL] [Abstract][Full Text] [Related]
5. The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells. Zhao L; Yue P; Lonial S; Khuri FR; Sun SY Mol Cancer Ther; 2011 Dec; 10(12):2415-25. PubMed ID: 21914854 [TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related]
7. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation. Fan S; Li Y; Yue P; Khuri FR; Sun SY Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945 [TBL] [Abstract][Full Text] [Related]
8. The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway. Elrod HA; Lin YD; Yue P; Wang X; Lonial S; Khuri FR; Sun SY Mol Cancer Ther; 2007 Jul; 6(7):2029-38. PubMed ID: 17604333 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers. Nam SY; Jung GA; Hur GC; Chung HY; Kim WH; Seol DW; Lee BL Cancer Sci; 2003 Dec; 94(12):1066-73. PubMed ID: 14662022 [TBL] [Abstract][Full Text] [Related]
10. mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis. Zhao L; Yue P; Khuri FR; Sun SY Cancer Res; 2013 Mar; 73(6):1946-57. PubMed ID: 23319802 [TBL] [Abstract][Full Text] [Related]
11. c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589. Kauh J; Fan S; Xia M; Yue P; Yang L; Khuri FR; Sun SY PLoS One; 2010 Apr; 5(4):e10376. PubMed ID: 20442774 [TBL] [Abstract][Full Text] [Related]
12. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP. Zhang T; Wang X; He D; Jin X; Guo P Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L). Min KJ; Seo BR; Bae YC; Yoo YH; Kwon TK Cell Death Dis; 2014 Feb; 5(2):e1063. PubMed ID: 24556678 [TBL] [Abstract][Full Text] [Related]
14. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway. Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583 [TBL] [Abstract][Full Text] [Related]
15. Involvement of c-FLIP and survivin down-regulation in flexible heteroarotinoid-induced apoptosis and enhancement of TRAIL-initiated apoptosis in lung cancer cells. Lin Y; Liu X; Yue P; Benbrook DM; Berlin KD; Khuri FR; Sun SY Mol Cancer Ther; 2008 Nov; 7(11):3556-65. PubMed ID: 19001438 [TBL] [Abstract][Full Text] [Related]
16. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Panner A; Crane CA; Weng C; Feletti A; Parsa AT; Pieper RO Cancer Res; 2009 Oct; 69(20):7911-6. PubMed ID: 19808964 [TBL] [Abstract][Full Text] [Related]
17. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis. Raja SM; Chen S; Yue P; Acker TM; Lefkove B; Arbiser JL; Khuri FR; Sun SY Mol Cancer Ther; 2008 Jul; 7(7):2212-23. PubMed ID: 18645030 [TBL] [Abstract][Full Text] [Related]
18. Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Wang X; Chen W; Zeng W; Bai L; Tesfaigzi Y; Belinsky SA; Lin Y Mol Cancer Ther; 2008 May; 7(5):1156-63. PubMed ID: 18483303 [TBL] [Abstract][Full Text] [Related]
19. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression. Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432 [TBL] [Abstract][Full Text] [Related]
20. Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3. Chen S; Cao W; Yue P; Hao C; Khuri FR; Sun SY Cancer Res; 2011 Oct; 71(19):6270-81. PubMed ID: 21868755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]